Holt Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $223K | Hold |
1,200
| – | – | 0.04% | 144 |
|
2025
Q1 | $251K | Hold |
1,200
| – | – | 0.04% | 147 |
|
2024
Q4 | $213K | Sell |
1,200
-120
| -9% | -$21.3K | 0.03% | 149 |
|
2024
Q3 | $261K | Buy |
1,320
+20
| +2% | +$3.95K | 0.04% | 145 |
|
2024
Q2 | $223K | Sell |
1,300
-184
| -12% | -$31.6K | 0.05% | 139 |
|
2024
Q1 | $270K | Buy |
1,484
+34
| +2% | +$6.19K | 0.04% | 144 |
|
2023
Q4 | $225K | Hold |
1,450
| – | – | 0.04% | 149 |
|
2023
Q3 | $216K | Buy |
+1,450
| New | +$216K | 0.04% | 145 |
|
2023
Q2 | – | Sell |
-1,750
| Closed | -$279K | – | 153 |
|
2023
Q1 | $279K | Hold |
1,750
| – | – | 0.06% | 133 |
|
2022
Q4 | $283K | Hold |
1,750
| – | – | 0.06% | 135 |
|
2022
Q3 | $235K | Hold |
1,750
| – | – | 0.07% | 130 |
|
2022
Q2 | $268K | Hold |
1,750
| – | – | 0.06% | 138 |
|
2022
Q1 | $284K | Hold |
1,750
| – | – | 0.05% | 138 |
|
2021
Q4 | $237K | Buy |
+1,750
| New | +$237K | 0.04% | 155 |
|
2016
Q2 | – | Sell |
-1,500
| Closed | -$86K | – | 126 |
|
2016
Q1 | $86K | Buy |
+1,500
| New | +$86K | 0.04% | 162 |
|
2015
Q4 | – | Sell |
-1,500
| Closed | -$82K | – | 112 |
|
2015
Q3 | $82K | Hold |
1,500
| – | – | 0.03% | 149 |
|
2015
Q2 | $101K | Hold |
1,500
| – | – | 0.04% | 142 |
|
2015
Q1 | $88K | Hold |
1,500
| – | – | 0.04% | 151 |
|
2014
Q4 | $98K | Buy |
+1,500
| New | +$98K | 0.04% | 144 |
|
2014
Q3 | – | Sell |
-1,500
| Closed | -$85K | – | 107 |
|
2014
Q2 | $85K | Buy |
1,500
+600
| +67% | +$34K | 0.05% | 125 |
|
2014
Q1 | $46K | Hold |
900
| – | – | 0.03% | 182 |
|
2013
Q4 | $48K | Buy |
+900
| New | +$48K | 0.03% | 181 |
|